Export

Daunorubicin
Essential medicine status
General description
Daunorubicin is an anthracycline antineoplastic agent that inhibits DNA and RNA synthesis. It is used in treatment protocols for acute lymphoblastic leukaemia, acute myelogenous leukaemia and acute promyelocytic leukaemia.
INN
Daunorubicin
Medicine type
Chemical agent
EML status history
Therapeutic equivalent for
Wikipedia
Recommendations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 50 mg in vial (hydrochloride) powder for injection